- MedMitra AI secures ₹3 crore in pre-seed funding to develop AI-driven healthcare solutions.
- The platform focuses on general medicine and chronic care, aiming to improve efficiency and clinical outcomes.
MedMitra AI, a healthcare-focused artificial intelligence platform, has secured ₹3 crore in a pre-seed funding round. The investment was co-led by venture capital firms All In Capital and WEH Ventures, along with contributions from angel investors Rohan Khandelwal, Pawan Gupta, and Venkat Subramanyam.
The platform is developing autonomous AI agents to assist healthcare professionals with diagnosis, treatment, and prognosis tasks. By analyzing multimodal data, including patient history, lab results, prescriptions, and imaging, MedMitra AI aims to deliver precise and personalized care.
The company is currently focusing on general medicine and chronic care, seeking to improve clinical outcomes and address inefficiencies in India's healthcare system.
“Our mission is to create AI-driven solutions that seamlessly integrate into doctors’ workflows while prioritising reliability and clinical relevance,” said Shivangi Sharma, co-founder of MedMitra AI and an AI graduate from Northwestern University.
The funding will be used to expand the company’s team, accelerate product development, and enhance its market presence. MedMitra AI also plans to introduce a specialized version of its platform for medical students, to improve medical education and prepare students for practical challenges.
India’s AI in healthcare market is projected to grow significantly, reaching $8.73 billion by 2030, with a compound annual growth rate (CAGR) of 41.8%.
Factors such as technological advancements, increased healthcare spending, and government initiatives like the India AI Mission are driving this growth.
Edited by Harshajit Sarmah
